These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 12360428

  • 1. Slowly tapering off steroids protects the graft against hepatitis C recurrence after liver transplantation.
    Brillanti S, Vivarelli M, De Ruvo N, Aden AA, Camaggi V, D'Errico A, Furlini G, Bellusci R, Roda E, Cavallari A.
    Liver Transpl; 2002 Oct; 8(10):884-8. PubMed ID: 12360428
    [Abstract] [Full Text] [Related]

  • 2. Significant improvement in the outcome of HCV-infected transplant recipients by avoiding rapid steroid tapering and potent induction immunosuppression.
    Berenguer M, Aguilera V, Prieto M, San Juan F, Rayón JM, Benlloch S, Berenguer J.
    J Hepatol; 2006 Apr; 44(4):717-22. PubMed ID: 16487616
    [Abstract] [Full Text] [Related]

  • 3. Histological and clinical outcome after liver transplantation for hepatitis C.
    Shuhart MC, Bronner MP, Gretch DR, Thomassen LV, Wartelle CF, Tateyama H, Emerson SS, Perkins JD, Carithers RL.
    Hepatology; 1997 Dec; 26(6):1646-52. PubMed ID: 9398011
    [Abstract] [Full Text] [Related]

  • 4. Liver transplantation for HCV cirrhosis: improved survival in recent years and increased severity of recurrent disease in female recipients: results of a long term retrospective study.
    Belli LS, Burroughs AK, Burra P, Alberti AB, Samonakis D, Cammà C, De Carlis L, Minola E, Quaglia A, Zavaglia C, Vangeli M, Patch D, Dhillon A, Cillo U, Guido M, Fagiuoli S, Giacomoni A, Slim OA, Airoldi A, Boninsegna S, Davidson BR, Rolles K, Pinzello G.
    Liver Transpl; 2007 May; 13(5):733-40. PubMed ID: 17370330
    [Abstract] [Full Text] [Related]

  • 5. Survival and hepatitis C virus recurrence after liver transplantation in HIV- and hepatitis C virus-coinfected patients: experience in a single center.
    Testillano M, Fernandez JR, Suarez MJ, Gastaca M, Bustamante J, Pijoan JI, Montejo M, Valdivieso A, Ruiz P, Gonzalez J, Ortiz de Urbina J.
    Transplant Proc; 2009 Apr; 41(3):1041-3. PubMed ID: 19376421
    [Abstract] [Full Text] [Related]

  • 6. Prolonged rewarming time during allograft implantation predisposes to recurrent hepatitis C infection after liver transplantation.
    Baron PW, Sindram D, Higdon D, Howell DN, Gottfried MR, Tuttle-Newhall JE, Clavien PA.
    Liver Transpl; 2000 Jul; 6(4):407-12. PubMed ID: 10915160
    [Abstract] [Full Text] [Related]

  • 7. Donor livers with steatosis are safe to use in hepatitis C virus-positive recipients.
    Burra P, Loreno M, Russo FP, Germani G, Galligioni A, Senzolo M, Cillo U, Zanus G, Fagiuoli S, Rugge M.
    Liver Transpl; 2009 Jun; 15(6):619-28. PubMed ID: 19479805
    [Abstract] [Full Text] [Related]

  • 8. Severe recurrent hepatitis C after liver retransplantation for hepatitis C virus-related graft cirrhosis.
    Berenguer M, Prieto M, Palau A, Rayón JM, Carrasco D, Juan FS, López-Labrador FX, Moreno R, Mir J, Berenguer J.
    Liver Transpl; 2003 Mar; 9(3):228-35. PubMed ID: 12619018
    [Abstract] [Full Text] [Related]

  • 9. Liver transplantation for hepatitis C: recurrence and disease progression in 300 patients.
    Testa G, Crippin JS, Netto GJ, Goldstein RM, Jennings LW, Brkic BS, Brooks BK, Levy MF, Gonwa TA, Klintmalm GB.
    Liver Transpl; 2000 Sep; 6(5):553-61. PubMed ID: 10980053
    [Abstract] [Full Text] [Related]

  • 10. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.
    de Arias AE, Haworth SE, Belli LS, Burra P, Pinzello G, Vangeli M, Minola E, Guido M, Boccagni P, De Feo TM, Torelli R, Cardillo M, Scalamogna M, Poli F.
    Liver Transpl; 2009 Apr; 15(4):390-9. PubMed ID: 19326408
    [Abstract] [Full Text] [Related]

  • 11. Recurrent hepatitis C virus disease after liver transplantation and concurrent biliary tract complications: poor outcome.
    Katz LH, Mor E, Brown M, Bar-Nathan N, Shaharabani E, Sulkes J, Pappo O, Tur-Kaspa R, Ben-Ari Z.
    Clin Transplant; 2006 Apr; 20(4):465-70. PubMed ID: 16842523
    [Abstract] [Full Text] [Related]

  • 12. A prospective randomized trial comparing tacrolimus and steroids with tacrolimus monotherapy in liver transplantation: the impact on recurrence of hepatitis C.
    Margarit C, Bilbao I, Castells L, Lopez I, Pou L, Allende E, Escartin A.
    Transpl Int; 2005 Dec; 18(12):1336-45. PubMed ID: 16297052
    [Abstract] [Full Text] [Related]

  • 13. Factors that identify survival after liver retransplantation for allograft failure caused by recurrent hepatitis C infection.
    Neff GW, O'Brien CB, Nery J, Shire NJ, Nishida S, delaGarza J, Montalbano M, Safdar K, Ruiz P, Rideman E, Gascon JA, Tzakis AG, Madariaga J, Rudich SM.
    Liver Transpl; 2004 Dec; 10(12):1497-503. PubMed ID: 15558835
    [Abstract] [Full Text] [Related]

  • 14. The natural history of recurrent hepatitis C and what influences this.
    Gane EJ.
    Liver Transpl; 2008 Oct; 14 Suppl 2():S36-44. PubMed ID: 18825724
    [Abstract] [Full Text] [Related]

  • 15. Natural history of hepatitis C and outcomes following liver transplantation.
    Rodriguez-Luna H, Vargas HE.
    Minerva Gastroenterol Dietol; 2004 Mar; 50(1):51-9. PubMed ID: 15719006
    [Abstract] [Full Text] [Related]

  • 16. Histologic recurrence of chronic hepatitis C virus in patients after living donor and deceased donor liver transplantation.
    Shiffman ML, Stravitz RT, Contos MJ, Mills AS, Sterling RK, Luketic VA, Sanyal AJ, Cotterell A, Maluf D, Posner MP, Fisher RA.
    Liver Transpl; 2004 Oct; 10(10):1248-55. PubMed ID: 15376308
    [Abstract] [Full Text] [Related]

  • 17. Impact of donor graft steatosis on overall outcome and viral recurrence after liver transplantation for hepatitis C virus cirrhosis.
    Briceño J, Ciria R, Pleguezuelo M, de la Mata M, Muntané J, Naranjo A, Sánchez-Hidalgo J, Marchal T, Rufián S, López-Cillero P.
    Liver Transpl; 2009 Jan; 15(1):37-48. PubMed ID: 19109846
    [Abstract] [Full Text] [Related]

  • 18. [Treatment of recurrent HCV infection after liver transplantation].
    Ostojić R.
    Acta Med Croatica; 2005 Jan; 59(5):443-6. PubMed ID: 16381241
    [Abstract] [Full Text] [Related]

  • 19. Hepatitis C recurrence is more severe after living donor compared to cadaveric liver transplantation.
    Garcia-Retortillo M, Forns X, Llovet JM, Navasa M, Feliu A, Massaguer A, Bruguera M, Fuster J, Garcia-Valdecasas JC, Rimola A.
    Hepatology; 2004 Sep; 40(3):699-707. PubMed ID: 15349910
    [Abstract] [Full Text] [Related]

  • 20. Older donor livers show early severe histological activity, fibrosis, and graft failure after liver transplantation for hepatitis C.
    Rayhill SC, Wu YM, Katz DA, Voigt MD, Labrecque DR, Kirby PA, Mitros FA, Kalil RS, Miller RA, Stolpen AH, Schmidt WN.
    Transplantation; 2007 Aug 15; 84(3):331-9. PubMed ID: 17700157
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.